Skip to main content

GMP Human AB Serum

R&D Systems, part of Bio-Techne | Catalog # HABS001-GMP-100ML

GMP grade media supplement for cell therapy workflows.
Catalog #
Availability
Size / Price
Qty
Loading...
HABS001-GMP-50B
HABS001-GMP-100ML

Key Product Details

Features

Small donor pool sourced, GMP-compliant human AB serum designed for clinical cell therapy workflows. Available in 100mL Bottle (HABS001-GMP-100mL) or 50mL bag (HABS001-GMP-50B).

Key Benefits

Species

Human

Product Summary for GMP Human AB Serum

GMP Human AB Serum is collected from a maximum of sixteen (16) healthy male donors of the AB serotype at FDA-licensed facilities in the United States. This material is defibrinated from source plasma AB using therapeutic grade recombinant human Thrombin. All donor units are tested for viral markers and found to be non-reactive or negative per 21 CFR 610.40 guidelines. GMP Human AB Serum is 0.1 μm sterile filtered, manufactured xeno-free, and does not contain non-human animal-derived components. GMP Human AB Serum is available in a 100 mL bottle format or 50 mL bag format.

Product Specifications

Osmolality

260-350 mOsm/kg

Sterility Testing

Tested following USP <71> sterility guidelines.

Cell Culture Testing

Donor Level Viral Testing: HBsAg, Anti-HCV, Anti-HIV-1/2, Syphilis, HIV p24 Ag, HBV-NAT, HIV-NAT, HCV-NAT, Anti-HTLV I/II, Anti-HBc IgM, Anti-HBc IgG, Parvo B19 DNA NAT, HAV RNA NAT, Zika RNA NAT, West Nile Virus NAT, Chagas. Pool Level Viral Testing: HBcAB, HTLV I/II, West Nile Virus, Chagas.

Scientific Data Images for GMP Human AB Serum

GMP Human AB Serum

GMP Human AB Serum available in 100 mL bottle or 50 mL closed process bag formats.

T cells cultured in GMP Human T Cell Media are viable and undergo robust expansion. 

Purified CD4+ and CD8+ T cells were cultured in a 6M G-Rex® Bioreactor in GMP Human T Cell Media (Catalog # CCM038-GMP-1L) with 10 ng/mL of Recombinant Human IL-7 GMP Protein (Catalog # BT-007-GMP), 10 ng/mL Recombinant Human IL-15 GMP Protein (Catalog # BT-015-GMP), and 5% GMP Human AB Serum (Catalog # HABS001-GMP-100ML). Activated T cells were left untreated (No TD) or transduced with Lentivirus (TD) to express CD19-CAR and eGFP. After 8 total days in culture, cells were assessed for viability (A) and cell density (B). Data is the average of 5 T cell donors with error bars ± SD.

GMP Human T Cell Media supports T cell editing with Lentivirus.

Purified CD4+ and CD8+ T cells were cultured in a 6M G-Rex® Bioreactor in GMP Human T Cell Media (Catalog # CCM038-GMP-1L) with 10 ng/mL of Recombinant Human IL-7 GMP Protein (Catalog # BT-007-GMP), 10 ng/mL Recombinant Human IL-15 GMP Protein (Catalog # BT-015-GMP), and 5% GMP Human AB Serum (Catalog # HABS001-GMP-100ML). Activated T cells were left untreated (No TD) or transduced with Lentivirus (TD) to express CD19-CAR and eGFP. After 8 total days in culture, cells were assessed for expression of the inserted cargo CD19-CAR by staining with CD19 recombinant Fluorokine (Catalog # ATM9269) by flow cytometry (A). Total viable edited cells were calculated by multiplying total live cells by % of CD19-CAR+ (B). Data is the average of 5 T cell donors with error bars ± SD.

Kit Contents for GMP Human AB Serum

  • 100 mL Bottle of GMP Human AB Serum (HABS001-GMP-100ML). OR
  • 50 mL Bag of GMP Human AB Serum (HABS001-GMP-50B).

Formulation, Preparation, and Storage

Shipping

The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the recommended temperature.

Storage

Store the unopened product frozen at ≤ -10 °C. See Use by Date on the Certificate of Analysis.

Product Documents for GMP Human AB Serum

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for GMP Human AB Serum

  • For preclinical, or clinical ex vivo use
  • This reagent should not be used beyond the use by date indicated on the CoA
  • Results may vary due to variations among primary T lymphocyte populations derived from different donors
Loading...
Loading...
Loading...